Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford undertakes world-leading vaccine research

The development of vaccines for the treatment or prevention of disease is a major strength at Oxford.

Active research programmes for the study of TB, malaria, HIV, HCV, HBV, Ebola virus, Zika virus and several childhood diseases such as meningococcal disease are ongoing.


People in this Theme